In this group of African-American men who had at least 4 family members with prostate cancer, rates of digital rectal examination (DRE) and prostate-specific antigen (PSA) screening were lower than those in the general African-American population (DRE 35% vs 45%; PSA 45% vs 65%).41,42. The gene discussed is KLK3; the disease is prostate carcinoma.